Trial NCT04236453

View at ClinicalTrials.gov 
Org. Study IDs: CR108649
Secondary IDs: 2019-002245-37 TMC114FD2HTX1005

Last trial update was posted on 2020-07-07

MeSH Interventions

Cobicistat Cobicistat mixture with darunavir Darunavir Emtricitabine Emtricitabine tenofovir alafenamide Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir

MeSH Conditions


Other Conditions

Healthy

Stopping Reasons

COVID-19 pandemic impacted the BE assessment of the trial. The clinical team decided to terminate the trial in order to start a new pivotal BE trial

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID